- Ongoing, recruitingTherapeutic confirmatory (Phase III)
CHemical OptImization of Cerebral Embolectomy in patients with acute stroke treated with mechanical thrombectomy 2 (CHOICE2TRIAL)
This study, CHOICE2TRIAL, is looking at a new way to help people who have had a severe stroke. It tests if a common clot-busting medicine, given after a procedure to remove a clot, can improve recovery and reduce brain damage.
For: Cerebral Embolectomy in patients with acute strokeSpain - AuthorisedTherapeutic confirmatory (Phase III)
Intra-arterial t-PA infusion during mechanical thrombectomy in acute ischemic stroke: a randomized trial.
This study is looking at a new way to treat severe strokes caused by a blocked blood vessel in the brain. It's testing if adding a clot-busting medicine directly into the brain's artery during an existing procedure can improve recovery and reduce disability for patients.
For: People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.Spain - AuthorisedTherapeutic confirmatory (Phase III)
Extending the time window for Tenecteplase by Effective RecanalizatioN of bAsilar artery occLusion in patients with POSTerior circulation stroke (POST ETERNAL)
This study looks at treating a severe type of stroke affecting the back of the brain. It's testing if a clot-busting medicine, Tenecteplase, can be given effectively over a wider time window to prevent disability or death and improve recovery.
For: Acute ischaemic stroke due to basilar artery occlusion.France